Date |
Speaker |
Title |
24th April 2006
|
Dr Roberto Motterlini
Vascular Biology Unit,
Northwick Park Institute for Medical Research
|
Heme oxygenase-1 in the cardiovascular system: from cell signalling to therapeutic applications |
8th May 2006
|
Dr Hon Leong
University of British Columbia
Vancouver, BC
|
Intracellular and extracellular fates of Plasminogen activator inhibitor type-1 (PAI-1) |
15th May 2006
|
Dr A Graham Pockley
Division of Clinical Sciences, Northern General Hospital,
Sheffield
| The immunoregulatory activity of the stress protein Gp96 and its Influence on cardiac allograft rejection responses |
22nd May 2006
|
Dr Michael Sacks
Engineered Tissue Mechanics Laboratory, Department of Bioengineering
University of Pittsburgh, USA
| Linking biomechanics and mechano-biology in native and engineered heart valves |
12th June 2006
|
Dr Sarah Calaghan
Senior Research Fellow,
Institute of Membrane & Systems Biology,
University of Leeds
|
Lipid raft domains and the control of cell signaling in the adult cardiac myocyte |
19th June 2006 |
Professor Yigal Pinto
University of Maastricht,
The Netherlands
|
From Movie Star to Governor: why does well trained cardiac muscle eventually progress to failure? |
26th June 2006
1-2 pm |
Professor Michael Schneider
Baylor College of Medicine
|
Cardioporesis: cardiac muscle cell creation and cardiac repair |
3rd July 2006
|
Dr Istvan Szokodi
Medical School Pecs,
Heart Institute of Pecs,
Hungary
|
Effects of Apelin on the cardiovascular system |
14th July 2006
|
Anand Ramamurthi
Department of Bioengineering and of Cell Biology and Anatomy (MUSC),
Clemson University and the Medical University of South Carolina, USA
|
Glycosaminoglycan-based scaffolds for regeneration of vascular and valvular elastin matrices |
